the potential HCV artnerships will make this a very interesting to watch...who will be 1st polymerase inhibitor to be studied with protease inhbitor, especially VX-950? coud be some big money to made with the right analysis or guess! one thing for sure, Gilead has shown to be very aggressive in HIV area so I would not underestimate them in HCV